Literature DB >> 440805

Kawasaki disease: effect of treatment on coronary artery involvement.

H Kato, S Koike, T Yokoyama.   

Abstract

Ninety-two patients with Kawasaki disease were treated with five different types of drug therapy: a steroid preparation (prednisolone), aspirin, an antibiotic, a combination of steroid plus aspirin, and a combination of steroid plus warfarin. One or two months after the onset of the disease, coronary angiography demonstrated coronary aneurysms in 20% of cases treated with an antibiotic alone, 64.7% of cases in the steroid-treated group, and 11% of those in the aspirin-treated group. These findings suggest that the steroid might act adversely to cause a progression of coronary lesions of the disease. The aspirin-treated group did not have a significantly lower incidence of coronary lesions compared with the group treated with an antibiotic alone. But in view of the fact that the direct cause of sudden death of the disease is thrombotic occlusion of a coronary artery, aspirin might act as the effective means for prevention of sudden death due to Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 440805

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  75 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.

Authors:  P A Brogan; A Bose; D Burgner; D Shingadia; R Tulloh; C Michie; N Klein; R Booy; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

Review 3.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 4.  New perspectives in the drug treatment of Kawasaki disease.

Authors:  D Shingadia; S T Shulman
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

Review 5.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

6.  Clinical trials in Kawasaki disease.

Authors:  Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

7.  The inclusion of corticosteroids in treatment regimens for Kawasaki disease: effect on coronary aneurysms.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

8.  Intravenous pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

9.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

10.  Coronary aneurysms in Kawasaki disease: follow-up observation by two-dimensional echocardiography.

Authors:  M Yanagisawa; S Yano; H Shiraishi; Y Nakajima; T Fujimoto; K Itoh
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.